Herbert J. Conrad

Former President Roche Pharmaceuticals US

Mr. Conrad became a Director of Celldex in March 2004. Mr. Conrad was the former president of Roche Pharmaceuticals in the United States from 1982 until his retirement in 1993. Since then he has served on the boards of Dura, UroCor, Sicor, GenVec (chairman), Bone Care International (chairman), Sapphire Therapeutics (chairman), was a co-founder of Reliant Pharmaceuticals, and is on the boards of Savient Pharmaceuticals, Pharmasset Inc., and the medical advisory board of Henry Schein Inc. He received B.S. and M.S. degrees from the Brooklyn College of Pharmacy and an honorary Doctorate in Humane Letters from Long Island University.